跳至主要内容
临床试验/CTRI/2019/03/018232
CTRI/2019/03/018232尚未招募2 期

Efficacy of Unani formulation in Pelvic Inflammatory Disease-A randomised standard controlled clinical study

ational institute of Unani medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Married women age group of 20-40 years
  • Mild to moderate PID as per CDC Criteria (CDC diagnostic criteria i.e. pelvic
  • or lower abdominal pain and uterine / adnexal or cervical motion tenderness and
  • more than or equal to 1 of its minor criteria i.e. fever(101 degree F), abnormal cervical or vaginal
  • mucopurulent discharge, abundant number of WBC on wet mount test of vaginal fluid, elevated ESR or CRP, positive test for cervical infection with N.
  • gonorrhoea or C. trachomatis include in this criteria)
  • Medical diagnosis of uncomplicated pelvic inflammatory disease(Sub-acute
  • PID with mild to moderate signs and symtoms)

排除标准

  • Severe PID and its Complications
  • Pregnant and lactating women
  • Systemic illnesses and malignancies
  • A history of uterine or pelvic or abdominal surgery and less than 30days before treatment

研究者

发起方
ational institute of Unani medicine

相似试验

nani formulation in Pelvic Inflammatory Disease | 临床试验